(Q40388152)

English

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Tao Z

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Connor RJ

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ashoori F

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dinney CP

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Munsell M

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Philopena JA

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Benedict WF

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

125-130

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700865

0 references

Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

21 January 2018

Salvage intravesical therapy with interferon-alpha 2b plus low dose bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom bacillus Calmette-Guerin alone previously failed

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700865

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700865

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40388152&oldid=1896736212"